20
Glaxosmithkline Research & Development Limited Brentford Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Clobetasone butyrate, Micronised, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-186 - Rev 02
This Chemical Type CEP, issued on August 06, 2013, remains in force until June 04, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 1090 associated with this CEP further emphasizes